HuagongsheHuagongshe Chemistry Print Report · For research reference only
FMOC-L-valine → N-[2-(tert-butyldimethylsilyloxy)ethyl]-N-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]-Nalpha-(9-fluorenylmethoxycarbonyl)-L-valine amide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | FMOC-L-valine | HCID 688217 | — |
| Reactant | N-[2-(tert-butyldimethylsilyloxy)ethyl]-N-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]amine | HCID 18460594 | — |
| Product | N-[2-(tert-butyldimethylsilyloxy)ethyl]-N-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]-Nalpha-(9-fluorenylmethoxycarbonyl)-L-valine amide | HCID 86758403 | — |
Reaction Steps
N-[2-(tert-Butyldimethylsilyloxy)ethyl]-N-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]amine (679 mg) and N-(9-fluorenylmethoxycarbonyl)-L-valine (865 mg) were treated in the same manner as in Preparation Example 9 to obtain the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06432957B1 |
| Source dataset | uspto-grants-2002_08 |
| ORD ID | ord-50524c34725f4556aeedde0cbb13ac1a |
| Source note | uspto-grants-2002_08 |